---
title: "Ocean Biomedical, Inc. (OCEA.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/OCEA.US.md"
symbol: "OCEA.US"
name: "Ocean Biomedical, Inc."
industry: "生物技术"
---

# Ocean Biomedical, Inc. (OCEA.US)

| Item | Detail |
|------|--------|
| Industry | 生物技术 |
| Location | 美股市场 |
| Website | [www.oceanbiomedical.com](https://www.oceanbiomedical.com) |

## Company Profile

Ocean Biomedical, Inc.是一家生物制药公司，专注于在美国发现和开发肿瘤学、纤维化和传染病领域的治疗产品。该公司的肿瘤学产品候选药物包括用于治疗非小细胞肺癌的 OCX-253 抗 Chi3l1 单靶点单克隆抗体和 OCX-410 抗 Chi3l1/PD-1 双特异性抗体；以及用于治疗多形性胶质母细胞瘤的 OCX-909 抗 Chi3l1/CTLA-4 双特异性抗体。其纤维化产品候选药物包括用于治疗特发性肺纤维化（IPF）和赫尔曼斯基 - 普德拉克综合症（HPS）的 OCF-203 抗 Chit1 小分子。该公司的传染病产品候选药物针对疟疾，包括用于预防 P 的 ODA-570...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.01 | 70/605 | - | - | - |
| PB | 0.00 | 451/605 | - | - | - |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/OCEA.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/OCEA.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/OCEA.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.